Challenges
Elena Simon is just an average teenage girl, one who enjoys dancing and acting, and plans on attending Harvard in the fall to study computer...
While we previously discussed how rare disease research has dramatically increased in both academic and industrial research, clinical trials of...
The need for CNS therapeutics is on the rise. Neurological diseases are expected to increase steadily in the coming years. Previously, we addressed...
More than $2 trillion dollars a year are spent on treatments for CNS disorders. One in three people over 80 currently has Alzheimer’s disease. With...
This is Part 3 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 2). Patient perspective (patient-centered outcomes...
This is Part 2 in a three-part series on patient-centered outcomes. (Check out Part 1 and Part 3). A personalized medicine approach to clinical...
This is Part 1 in a three-part series on patient-centered outcomes. (Check out Part 2 and Part 3). In different regulatory and research settings...
Working on the Rare Disease Science Challenge has shown me that everybody wants to support rare disease in many different ways, which is how the...
The Be HEARD Rare Disease Science Challenge is entering its next phase. After 77 applicants covering 67 rare diseases, we have decided on service...
Carlsbad, CA is soon to be home to San Diego’s own community laboratory space. Much along the lines of Genspace in NYC and BioCurious in Sunnyvale...
Search
Categories
- Artificial Intelligence (3)
- Challenges (63)
- Discovery & Innovation (193)
- Industry Trends (210)
- Infographics (17)
- News & Events (87)
- Open Science (39)
- Outsourcing (73)
- Press Releases (144)
- Research Exchanges (58)
- Research Services (94)
- Scientist In The News (152)
- Supplier Spotlight (50)
- Tech Snapshot (37)
- Webinars (34)